Part III – Applications of social software for pharmas
In my previous post I attempted to build an argument that “classical” consumer social media like Facebook is not a good fit for a pharmaceutical company due to the way they market innovative drugs.
Part II – Why pharmas don’t do social networking
If you understand how pharmaceuticals are sold, this is not surprising. What is surprising is that a lot of people seem to think it’s just a question of time before pharmaceutical companies like GSK get into social media. I claim that a fashion trend doesn’t make a business case. The buzz of social media and […]
Part I – Pharmas and social networking
I was talking to some folks at a big global pharma last week and I discovered that pharma doesn’t like social networking. (Give me a break – I’m a software security guy, I think about these things in terms of threats to intellectual property and I thought everyone “gets” social networking). If you understand how […]
Foreign Corrupt Practices Act: The DoJ and SEC Are Coming
There is compliance to industry regulation like PCI DSS 1.2 which is aimed at consumer protection and then there is compliance to government regulation like the FCPA which is aimed at maintaining a high ethical level of behavior and ensuring a level playing field of business. For a large global company like Monsanto, Merck or […]
